Clinical Trial Update: Use of Quetiapine as an Add on Therapy in the Treatment of Post Traumatic Stress Disorder [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating quetiapine as add-on therapy for post-traumatic stress disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• Quetiapine (quetiapine)

Snippet

Sponsor: AstraZeneca | Conditions: Post-Traumatic Stress Disorder | Phase 3 | Status: COMPLETED